Cargando…
Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial
OBJECTIVE: To assess the feasibility and efficacy of bladder training for troublesome lower urinary tract symptoms (LUTS) in Parkinson disease (PD). METHODS: In this single-center, single-blinded, randomized controlled trial, participants with a history of PD and LUTS were randomized to a 12-week bl...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274915/ https://www.ncbi.nlm.nih.gov/pubmed/32054791 http://dx.doi.org/10.1212/WNL.0000000000008931 |
_version_ | 1783542673779458048 |
---|---|
author | McDonald, Claire Rees, Jackie Winge, Kristian Newton, Julia L. Burn, David J. |
author_facet | McDonald, Claire Rees, Jackie Winge, Kristian Newton, Julia L. Burn, David J. |
author_sort | McDonald, Claire |
collection | PubMed |
description | OBJECTIVE: To assess the feasibility and efficacy of bladder training for troublesome lower urinary tract symptoms (LUTS) in Parkinson disease (PD). METHODS: In this single-center, single-blinded, randomized controlled trial, participants with a history of PD and LUTS were randomized to a 12-week bladder training program (BT) or conservative advice (CA). Outcome measures included a 3-day volume frequency diary, International Consultation on Incontinence Questionnaire (ICIQ)–Overactive Bladder Module, and ICIQ—Quality of Life Module. Co–primary endpoints were (1) patient perception of change and (2) change in number of urgency episodes at 12 weeks. Secondary endpoints included change in ICIQ scores, number of micturitions, and volume voided. RESULTS: Thirty-eight participants were randomized (18 to CA, 20 to BT). Both CA and BT were associated with significant improvements in volume voided, number of micturitions, symptom severity scores, and measures of quality of life (all p < 0.05). At 12 weeks, compared to CA, BT was associated with significant superiority on patient perception of improvement (p = 0.001), significantly greater reductions in number of voids in 24 hours (mean decrease 2.3 ± 0.8 voids vs 0.3 ± 0.5 [p < 0.05]), and greater reductions in interference with daily life (2.1 ± 0.8 point improvement vs 0.3 ± 0.7 point deterioration [p < 0.05]). BT was not associated with change in urgency episodes (mean change 2.4 ± 1.5 urgency episodes vs 3.5 ± 1.5 [p NS]). At 20 weeks, BT remained associated with greater improvement in interference in daily life. Loss of significance in other measures may reflect loss of power from loss to follow-up. CONCLUSION: This controlled trial demonstrated the potential benefits of BT for LUTS in PD. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with PD and LUTS, BT significantly increased patient perception of improvement but did not significantly reduce urgency episodes. |
format | Online Article Text |
id | pubmed-7274915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-72749152020-06-23 Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial McDonald, Claire Rees, Jackie Winge, Kristian Newton, Julia L. Burn, David J. Neurology Article OBJECTIVE: To assess the feasibility and efficacy of bladder training for troublesome lower urinary tract symptoms (LUTS) in Parkinson disease (PD). METHODS: In this single-center, single-blinded, randomized controlled trial, participants with a history of PD and LUTS were randomized to a 12-week bladder training program (BT) or conservative advice (CA). Outcome measures included a 3-day volume frequency diary, International Consultation on Incontinence Questionnaire (ICIQ)–Overactive Bladder Module, and ICIQ—Quality of Life Module. Co–primary endpoints were (1) patient perception of change and (2) change in number of urgency episodes at 12 weeks. Secondary endpoints included change in ICIQ scores, number of micturitions, and volume voided. RESULTS: Thirty-eight participants were randomized (18 to CA, 20 to BT). Both CA and BT were associated with significant improvements in volume voided, number of micturitions, symptom severity scores, and measures of quality of life (all p < 0.05). At 12 weeks, compared to CA, BT was associated with significant superiority on patient perception of improvement (p = 0.001), significantly greater reductions in number of voids in 24 hours (mean decrease 2.3 ± 0.8 voids vs 0.3 ± 0.5 [p < 0.05]), and greater reductions in interference with daily life (2.1 ± 0.8 point improvement vs 0.3 ± 0.7 point deterioration [p < 0.05]). BT was not associated with change in urgency episodes (mean change 2.4 ± 1.5 urgency episodes vs 3.5 ± 1.5 [p NS]). At 20 weeks, BT remained associated with greater improvement in interference in daily life. Loss of significance in other measures may reflect loss of power from loss to follow-up. CONCLUSION: This controlled trial demonstrated the potential benefits of BT for LUTS in PD. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with PD and LUTS, BT significantly increased patient perception of improvement but did not significantly reduce urgency episodes. Lippincott Williams & Wilkins 2020-03-31 /pmc/articles/PMC7274915/ /pubmed/32054791 http://dx.doi.org/10.1212/WNL.0000000000008931 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article McDonald, Claire Rees, Jackie Winge, Kristian Newton, Julia L. Burn, David J. Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial |
title | Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial |
title_full | Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial |
title_fullStr | Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial |
title_full_unstemmed | Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial |
title_short | Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial |
title_sort | bladder training for urinary tract symptoms in parkinson disease: a randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274915/ https://www.ncbi.nlm.nih.gov/pubmed/32054791 http://dx.doi.org/10.1212/WNL.0000000000008931 |
work_keys_str_mv | AT mcdonaldclaire bladdertrainingforurinarytractsymptomsinparkinsondiseasearandomizedcontrolledtrial AT reesjackie bladdertrainingforurinarytractsymptomsinparkinsondiseasearandomizedcontrolledtrial AT wingekristian bladdertrainingforurinarytractsymptomsinparkinsondiseasearandomizedcontrolledtrial AT newtonjulial bladdertrainingforurinarytractsymptomsinparkinsondiseasearandomizedcontrolledtrial AT burndavidj bladdertrainingforurinarytractsymptomsinparkinsondiseasearandomizedcontrolledtrial |